SCM
PMVP icon

Sio Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History

Sio Capital Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.53M Sell
2,634,137
-442,443
-14% -$568K 0.58% 40
2026
Q1 		$3.81M Buy
3,076,580
+440,032
+17% +$560K 0.55% 44
2025
Q4 		$3.3M Hold
2,636,548
– – 0.52% 40
2025
Q3 		$3.69M Sell
2,636,548
-1,098,848
-29% -$1.52M 0.93% 28
2025
Q2 		$3.96M Hold
3,735,396
– – 1.51% 20
2025
Q1 		$4.07M Buy
3,735,396
+163,229
+5% +$222K 1.21% 21
2024
Q4 		$5.39M Buy
3,572,167
+357,928
+11% +$567K 1.52% 23
2024
Q3 		$4.79M Buy
3,214,239
+505,831
+19% +$782K 1.9% 18
2024
Q2 		$4.39M Buy
+2,708,408
New +$4.88M 1.19% 21
2020
Q4 		– Sell
-1,000
Closed -$36K – 105
2020
Q3 		$36K Buy
+1,000
New +$36.8K 0.01% 89

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sio Capital Management's PMVP Position: Q2 2026 in Review

Sio Capital Management reduced its PMV Pharmaceuticals (PMVP) stake by 14% in Q2 2026, selling an estimated $568K and leaving 2,634,137 shares worth $3.53M. The position accounts for 0.58% of the portfolio, ranked #40.

Sio Capital Management first reported a position in PMVP in Q3 2020 and has held it in 10 quarters since. The position peaked at $5.39M in Q4 2024. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • Sio Capital Management held 2,634,137 shares of PMV Pharmaceuticals worth $3.53M as of Q2 2026.
  • Sio Capital Management sold 442,443 PMV Pharmaceuticals shares in Q2 2026, an estimated $568K.
  • PMV Pharmaceuticals made up 0.58% of Sio Capital Management's portfolio in Q2 2026, its #40 holding.
  • Sio Capital Management first reported a position in PMV Pharmaceuticals in Q3 2020 and has held it in 10 quarters since.
  • Sio Capital Management's PMV Pharmaceuticals position peaked at $5.39M in Q4 2024.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.